Analytical methods for the quantification of ibandronate in body fluids and bone.
The accurate determination of bisphosphonate levels in bone and biological fluids is important in both clinical and pharmacological/toxicological studies. Ibandronate is a potent nitrogen-containing bisphosphonate containing a tertiary amine group, which does not easily form chromophore derivatives that can be detected by UV light or fluorescence emissions. The current report describes the methodology and validation of a GC-MS assay for ibandronate in serum/plasma and urine, a similar, modified GC-MS method for measurement of bone ibandronate levels, and an ELISA for ibandronate determination in serum/plasma. The range of quantification for the GC-MS was 1-100 ng/ml and 2-7500 ng/ml in plasma or serum and urine, respectively, and 50-1600 pg/ml (potentially 10-320 pg/ml depending on sample size) for the ELISA in plasma or serum. These assays were comparable. The practical application of the assays in preclinical and clinical studies is briefly reviewed.
Endele
Richard
R
Roche Diagnostics GmbH, Pharma Research Penzberg, Germany.
Loew
Heiner
H
Bauss
Frieder
F
D000818:Animals; D001826:Body Fluids / Q000737:chemistry*; D001862:Bone Resorption; D004164:Diphosphonates / Q000032:analysis* / Q000097:blood / Q000652:urine; D004797:Enzyme-Linked Immunosorbent Assay; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D000077557:Ibandronic Acid; D051381:Rats; D012015:Reference Standards
D004164:Diphosphonates; D000077557:Ibandronic Acid